Market Place
Sourcing Support
Biologics gaining ground in HS, but more support needed: Spherix
11 Nov 2024 //
FIERCE PHARMA
AbbVie`s Skyrizi overtakes Humira as top sales driver
31 Oct 2024 //
FIERCE PHARMA
Prime Therapeutics Announces Cost-Effective Humira Biosimilar
07 Oct 2024 //
PR NEWSWIRE
Biocon Biologics to Present Dermatology Data at EADV Congress 2024
25 Sep 2024 //
PR NEWSWIRE
Alchemab appoints Co-Founder Jane Osbourn as Chief Executive Officer
12 Sep 2024 //
PR NEWSWIRE
UnitedHealth To Remove AbbVie`s Humira From Some US Reimbursement Lists
10 Sep 2024 //
REUTERS
Alvotech`s Biologic Simlandi (Adalimumab) Receives Suppl Approvals in US
26 Aug 2024 //
FDA
Amgen`s Biologic Amjevita (Adalimumab) Receives Suppl Approvals in US
19 Aug 2024 //
FDA
Celltrion`s Humira Biosimilar Added To Costco Prescription Program
12 Aug 2024 //
PR NEWSWIRE
Teva Reports Strong Q2 Growth, Raises 2024 Guidance
31 Jul 2024 //
GLOBENEWSWIRE
Samsung Bioepis Releases Third Quarter 2024 US Biosimilar Market Report
11 Jul 2024 //
GLOBENEWSWIRE
Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh)
27 Jun 2024 //
GLOBENEWSWIRE
AbbVie inks immune disorder drug licensing deal with China`s FutureGen
14 Jun 2024 //
REUTERS
AbbVie`s tight grip on Humira market raises concerns about biosimilars
08 Jun 2024 //
REUTERS
Fresenius Kabi Usa`s Generic Adalimumab-Aacf Receives Approval in US
04 Jun 2024 //
FDA
Senators strike bipartisan tone on more pharma patent reforms
21 May 2024 //
ENDPTS
Teva, Alvotech`s SIMLANDI Adalimumab Biosimilar Now Available In US
20 May 2024 //
GLOBENEWSWIRE
Boehringer enlists Cigna`s Quallent to expand Humira biosimilar reach
14 May 2024 //
FIERCE PHARMA
Boehringer Ingelheim Expands Access To Adalimumab Biosimilar Injection
13 May 2024 //
PR NEWSWIRE
Celltrion HUMIRA Biosimilar At Low Wholesale Acquisition Cost
09 May 2024 //
PR NEWSWIRE
Inside CVS Caremark’s move that broke Humira’s hold on the market
08 May 2024 //
ENDPTS
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
08 May 2024 //
REUTERS
Amid promising launch of Humira biosim, Sandoz sees 6% growth
07 May 2024 //
FIERCE PHARMA
FDA approves Boehringer Ingelheim’s Cyltezo for inflammatory ailments
02 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Boehringer puts a target on Humira, says pushing it off formularies is necessary
02 May 2024 //
ENDPTS
FDA Approves BI`s Citrate-Free Cyltezo, Humira Biosimilar
01 May 2024 //
PR NEWSWIRE
Quallent US Deal for Patient Savings with Humira® Biosimilar
30 Apr 2024 //
GLOBENEWSWIRE
Drugmaker AbbVie expects Humira volume erosion to worsen
27 Apr 2024 //
REUTERS
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
25 Apr 2024 //
REUTERS
Boehringer Ingelheim plots 25 new launches over the next decade
16 Apr 2024 //
FIERCE PHARMA
Boehringer to lay off salespeople as Humira biosimilar sales lag
04 Apr 2024 //
REUTERS
Roivant`s anti-inflammatory drug shows promise in mid-stage study
03 Apr 2024 //
REUTERS
Teva and Alvotech`s Humira biosimilar finally snags FDA approval
24 Feb 2024 //
FIERCE PHARMA
Alvotech`s Biologic Simlandi (adalimumab) Receives Approval in the U.S.
23 Feb 2024 //
FDA
Organon Announces HADLIMA Has Been Selected by the US Department of VA
20 Feb 2024 //
BUSINESSWIRE
Organon`s Humira biosimilar gets exclusive spot on VA formulary
16 Feb 2024 //
ENDPTS
Real Humira competition may not arrive until 2026, AbbVie execs tell investors
02 Feb 2024 //
ENDPTS
Humira biosimilar market remains stagnant, with AbbVie losing 2% of market share
17 Jan 2024 //
ENDPTS
CVS will remove AbbVie`s Humira from some drug reimbursement lists in April
03 Jan 2024 //
REUTERS
Mylan`s Biologic Hulio (adalimumab) Receives Approval in the U.S.
15 Dec 2023 //
FDA
AbbVie`s Humira, J&J`s Darzalex top ICER`s annual price-hike list
11 Dec 2023 //
FIERCE PHARMA
AbbVie bets that nearly $20B in deals can bring it into the post-Humira future
07 Dec 2023 //
ENDPTS
Celltrion`s Biologic Yuflyma (adalimumab) Receives Approval in the U.S.
30 Nov 2023 //
FDA
Sandoz launches Hyrimoz® (adalimumab) high-concentration formulation in Europe
21 Nov 2023 //
GLOBENEWSWIRE
FDA approves an unbranded version of megablockbuster Humira
08 Nov 2023 //
ENDPTS
Samsung Bioepis & Organon Announce Acceptance of sBLA for Interchangeability Designation for HADLIMA
07 Nov 2023 //
GLOBENEWSWIRE
AbbVie`s Biologic Humira (adalimumab) Receives Approval in the U.S.
03 Nov 2023 //
FDA
Fresenius Kabi`s Biologic Idacio (adalimumab) Receives Approval in the U.S.
31 Oct 2023 //
FDA
AbbVie focuses on Skyrizi, Rinvoq growth, eyes external strategies
27 Oct 2023 //
ENDPTS
Celltrion USA announces distribution and incorporation of YUFLYMA
26 Oct 2023 //
BUSINESSWIRE
AbbVie still controls more than 97% of the US market of Humira
10 Oct 2023 //
ENDPTS
Celltrion USA has signed a contract with Ventegra® to add Yuflyma
05 Oct 2023 //
BUSINESSWIRE
Pfizer`s Biologic Abrilada (adalimumab) Receives Approval in the U.S.
04 Oct 2023 //
FDA
Boehringer launches 81% discounted biosimilar of AbbVie`s Humira
03 Oct 2023 //
REUTERS
Alvotech Provides U.S. Regulatory Update on AVT02
20 Sep 2023 //
GLOBENEWSWIRE
Coherus` Biologic Yusimry (Adalimumab) Receives Approval in the U.S.
13 Sep 2023 //
FDA
Sandoz`s Biologic Hyrimoz (Adalimumab) Receives Approval in the U.S.
08 Sep 2023 //
FDA
Celltrion`s Biologic Yuflyma (Adalimumab) Receives Approval in the U.S.
06 Sep 2023 //
FDA
